New GABA-Targeting Therapies for the Treatment of Seizures and Epilepsy: I. Role of GABA as a Modulator of Seizure Activity and Recently Approved Medications Acting on the GABA System

Akyuz E, Polat AK, Eroglu E, Kullu I, Angelopoulou E, Paudel YN. Revisiting the role of neurotransmitters in epilepsy: an updated review. Life Sci. 2021;265: 118826.

Article  CAS  PubMed  Google Scholar 

Perucca E, White HS, Bialer M. New GABA-targeting therapies for the treatment of seizures and epilepsy. II. Treatments in clinical development. CNS Drugs. https://doi.org/10.1007/s40263-023-01025-4.

Bergmann KJ. Progabide: a new GABA-mimetic agent in clinical use. Clin Neuropharmacol. 1985;8:13–26.

Article  CAS  PubMed  Google Scholar 

Grant SM, Heel RC. Vigabatrin: a r review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs. 1991;41:889–926.

Article  CAS  PubMed  Google Scholar 

Schachter SC. A review of the antiepileptic drug tiagabine. Clin Neuropharmacol. 1999;22:312–7.

CAS  PubMed  Google Scholar 

Löscher W. Single-target versus multi-target drugs versus combinations of drugs with multiple targets: preclinical and clinical evidence for the treatment or prevention of epilepsy. Front Pharmacol. 2021;12: 730257.

Article  PubMed  PubMed Central  Google Scholar 

Treiman DM. GABAergic mechanisms in epilepsy. Epilepsia. 2001;42(Suppl. 3):8–12.

Article  PubMed  Google Scholar 

Liu YQ, Yu F, Liu WH, He XH, Peng BW. Dysfunction of hippocampal interneurons in epilepsy. Neurosci Bull. 2014;30:985–98.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sarlo GL, Holton KF. Brain concentrations of glutamate and GABA in human epilepsy: a review. Seizure. 2021;91:213–27.

Article  PubMed  Google Scholar 

Nohria V, Giller E. Ganaxolone. Neurotherapeutics. 2007;4:102–5.

Article  CAS  PubMed  PubMed Central  Google Scholar 

White HS, Rho JM, editors. Mechanisms of action of antiepileptic drugs. New York: Professional Communications, Inc.; 2010.

Google Scholar 

Squires RF, Saederup E, Crawley JN, Skolnick P, Paul SM. Convulsant potencies of tetrazoles are highly correlated with actions on GABA/benzodiazepine/picrotoxin receptor complexes in brain. Life Sci. 1984;35:1439–44.

Article  CAS  PubMed  Google Scholar 

Newland CF, Cull-Candy SG. On the mechanism of action of picrotoxin on GABA receptor channels in dissociated sympathetic neurones of the rat. J Physiol. 1992;447:191–213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Absalom NL, Liao VWY, Johannesen KMH, Gardella E, Jacobs J, Lesca G, et al. Gain-of-function and loss-of-function GABRB3 variants lead to distinct clinical phenotypes in patients with developmental and epileptic encephalopathies. Nat Commun. 2022;13:1822.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chuang SH, Reddy DS. Genetic and molecular regulation of extrasynaptic GABA-A receptors in the brain: therapeutic insights for epilepsy. J Pharmacol Exp Ther. 2018;364:180–97.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Feng Y, Wei ZH, Liu C, Li GY, Qiao XZ, Gan YJ, et al. Genetic variations in GABA metabolism and epilepsy. Seizure. 2022;101:22–9.

Article  PubMed  Google Scholar 

Cossette P, Lachance-Touchette P, Rouleau GA. Mutated GABAA receptor subunits in idiopathic generalized epilepsy. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper’s basic mechanisms of the epilepsies. 4th ed. Bethesda (MD): National Center for Biotechnology Information (US); 2012: p. 827–46.

Hernandez CC, Tian X, Hu N, Shen W, Catron MA, Yang Y, et al. Dravet syndrome-associated mutations in GABRA1, GABRB2 and GABRG2 define the genetic landscape of defects of GABAA receptors. Brain Commun. 2021;3:fcab033.

Article  PubMed  PubMed Central  Google Scholar 

Kang J-Q. Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies. Epilepsy Res. 2017;137:9–18.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Macdonald RL, Kang JQ, Gallagher MJ. GABAA receptor subunit mutations and genetic epilepsies. In: Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, editors. Jasper's basic mechanisms of the epilepsies. 4th ed. Bethesda (MD): National Center for Biotechnology Information (US); 2012: p. 857–68.

Maillard PY, Baer S, Schaefer É, Desnous B, Villeneuve N, Lépine A, et al. Molecular and clinical descriptions of patients with GABAA receptor gene variants (GABRA1, GABRB2, GABRB3, GABRG2): a cohort study, review of literature, and genotype-phenotype correlation. Epilepsia. 2022;63:2519–33.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Riaz M, Abbasi MH, Sheikh N, Saleem T, Virk AO. GABRA1 and GABRA6 gene mutations in idiopathic generalized epilepsy patients. Seizure. 2021;93:88–94.

Article  PubMed  Google Scholar 

Symonds JD, Zuberi SM, Johnson MR. Advances in epilepsy gene discovery and implications for epilepsy diagnosis and treatment. Curr Opin Neurol. 2017;30:193–9.

Article  PubMed  Google Scholar 

Iadarola MJ, Gale K. Substantia nigra: site of anticonvulsant activity mediated by gamma-aminobutyric acid. Science. 1982;218:1237–40.

Article  CAS  PubMed  Google Scholar 

Gale K. Subcortical structures and pathways involved in convulsive seizure generation. J Clin Neurophysiol. 1992;9:264–77.

Article  CAS  PubMed  Google Scholar 

Snodgrass SR. GABA and epilepsy: their complex relationship and the evolution of our understanding. J Child Neurol. 1992;7:77–86.

Article  CAS  PubMed  Google Scholar 

Hosford DA, Wang Y. Utility of the lethargic (lh/lh) mouse model of absence seizures in predicting the effects of lamotrigine, vigabatrin, tiagabine, gabapentin, and topiramate against human absence seizures. Epilepsia. 1997;38:408–14.

Article  CAS  PubMed  Google Scholar 

Berkovic SF. Aggravation of generalized epilepsies. Epilepsia. 1998;39(Suppl. 3):S11–4.

Article  CAS  PubMed  Google Scholar 

Liu L, Zheng T, Morris MJ, Wallengren C, Clarke AL, Reid CA, et al. The mechanism of carbamazepine aggravation of absence seizures. J Pharmacol Exp Ther. 2006;319:790–8.

Article  CAS  PubMed  Google Scholar 

Zheng T, Clarke AL, Morris MJ, Reid CA, Petrou S, O’Brien TJ. Oxcarbazepine, not its active metabolite, potentiates GABAA activation and aggravates absence seizures. Epilepsia. 2009;50:83–7.

Article  CAS  PubMed  Google Scholar 

Hosford DA, Clark S, Cao Z, Wilson WA Jr, Lin FH, Morrisett RA, et al. The role of GABAB receptor activation in absence seizures of lethargic (lh/lh) mice. Science. 1992;257:398–401.

Article  CAS  PubMed  Google Scholar 

Motalli R, Louvel J, Tancredi V, Kurcewicz I, Wan-Chow-Wah D, Pumain R, et al. GABA(B) receptor activation promotes seizure activity in the juvenile rat hippocampus. J Neurophysiol. 1999;82:638–47.

Article  CAS  PubMed  Google Scholar 

Mares P, Tabashidze N. Contradictory effects of GABA-B receptor agonists on cortical epileptic afterdischarges in immature rats. Brain Res Bull. 2008;75:173–8.

Article  CAS  PubMed  Google Scholar 

Avoli M, Lévesque M. GABAB Receptors: are they missing in action in focal epilepsy research? Curr Neuropharmacol. 2022;20:1704–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem. 2006;98:641–53.

Article  CAS  PubMed  Google Scholar 

Chebib M, Johnston GA. The “ABC” of GABA receptors: a brief review. Clin Exp Pharmacol Physiol. 1999;26:937–40.

Article  CAS  PubMed  Google Scholar 

Sieghart W, Savić MM. International Union of Basic and Clinical Pharmacology. CVI: GABAA receptor subtype- and function-selective ligands: key issues in translation to humans. Pharmacol Rev. 2018;70:836–78.

Olsen RW, Tobin AJ. Molecular biology of GABAA receptors. FASEB J. 1990;4:1469–80.

Article  CAS  PubMed  Google Scholar 

Sigel E, Steinmann ME. Structure, function, and modulation of GABA(A) receptors. J Biol Chem. 2012;287:40224–31.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Castellano D, Shepard RD, Lu W. Looking for novelty in an “old” receptor: recent advances toward our understanding of GABAARs and their implications in receptor pharmacology. Front Neurosci. 2021;14: 616298.

Article  PubMed  PubMed Central  Google Scholar 

Comments (0)

No login
gif